MYL9 and breast cancer: The results from Prognoscan and Kaplan–Meier plotter databases showed that MYL9 expression correlated significantly with prognosis in lung cancer, breast cancer, colorectal cancer, brain glioma, prostate cancer, especially ovarian cancer and gastric cancer.